
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs
AstraZeneca said it was shifting the production of some medicines sold in the United States from Europe to the US, to counter the impact of Donald Trump’s trade tariffs. Speaking as the company reported higher sales and profits for the first quarter, the …